Truist Financial Cuts Integral Ad Science (NASDAQ:IAS) Price Target to $16.00

Integral Ad Science (NASDAQ:IAS) had its price target cut by Truist Financial from $18.00 to $16.00 in a report issued on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock.

Several other research analysts have also issued reports on IAS. Morgan Stanley raised their price target on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 23rd. Raymond James upped their price target on shares of Integral Ad Science from $13.00 to $15.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a research report on Monday, August 5th. Oppenheimer cut their target price on Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday. Finally, Barclays lifted their target price on Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Monday, August 5th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $15.70.

Integral Ad Science Stock Down 6.1 %

Shares of NASDAQ IAS opened at $10.11 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.76. Integral Ad Science has a 1 year low of $7.98 and a 1 year high of $17.53. The company has a 50 day simple moving average of $11.09 and a 200 day simple moving average of $10.47. The firm has a market cap of $1.64 billion, a PE ratio of 50.55, a price-to-earnings-growth ratio of 1.46 and a beta of 1.52.

Integral Ad Science (NASDAQ:IAS) last announced its earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.08 by $0.02. The firm had revenue of $133.50 million for the quarter, compared to the consensus estimate of $138.06 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.09) EPS. On average, research analysts forecast that Integral Ad Science will post 0.25 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Tania Secor sold 5,240 shares of Integral Ad Science stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $52,976.40. Following the transaction, the chief financial officer now owns 248,223 shares of the company’s stock, valued at $2,509,534.53. The trade was a 2.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction on Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the sale, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at $2,423,457.99. The trade was a 4.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 23,006 shares of company stock worth $240,296. Insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integral Ad Science

A number of institutional investors have recently added to or reduced their stakes in the company. Point72 DIFC Ltd bought a new stake in shares of Integral Ad Science during the 3rd quarter worth $41,000. nVerses Capital LLC bought a new stake in Integral Ad Science in the third quarter worth about $45,000. Ameritas Investment Partners Inc. boosted its stake in Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after acquiring an additional 1,924 shares during the last quarter. Quantbot Technologies LP bought a new position in shares of Integral Ad Science during the 3rd quarter valued at approximately $106,000. Finally, XTX Topco Ltd purchased a new stake in shares of Integral Ad Science during the 2nd quarter worth approximately $113,000. 95.78% of the stock is owned by institutional investors.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.